Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 1
1965 1
1972 1
1973 1
1974 1
1975 4
1976 2
1978 4
1979 1
1981 2
1982 1
1983 2
1984 4
1985 1
1987 2
1989 5
1990 2
1991 2
1992 1
1993 1
1994 5
1995 5
1996 3
1998 7
1999 1
2000 10
2001 3
2002 5
2003 3
2004 6
2005 5
2006 2
2007 7
2008 7
2009 10
2010 8
2011 5
2012 8
2013 9
2014 6
2015 6
2016 5
2017 8
2018 12
2019 15
2020 9
2021 15
2022 8
2023 11
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Results by year

Filters applied: . Clear all
Page 1
N-[2-(3-cyanophenyl)-3-(4-(2-[18F]fluorethoxy)phenyl)-1-methylpropyl]-2-(5-methyl-2-pyridyloxy)-2-methylproponamide.
Chopra A. Chopra A. 2008 Feb 28 [updated 2008 Mar 25]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2008 Feb 28 [updated 2008 Mar 25]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641528 Free Books & Documents. Review.
In an effort to develop a PET ligand for CB1R with a longer half-life, N-[2-(3-cyanophenyl)-3-(4-(2-[(18)F]fluoroethoxy)phenyl)-1-methylpropyl]-2-(5-methyl-2-pyridyloxy)-2-methylpropanamide ([(18)F]MK-9470), a compound labeled with radioactive fluoride ((18)F), was …
In an effort to develop a PET ligand for CB1R with a longer half-life, N-[2-(3-cyanophenyl)-3-(4-(2-[(18)F]fluoroethoxy)phenyl)-1-methylprop …
RTK-Dependent Inducible Degradation of Mutant PI3Kα Drives GDC-0077 (Inavolisib) Efficacy.
Song KW, Edgar KA, Hanan EJ, Hafner M, Oeh J, Merchant M, Sampath D, Nannini MA, Hong R, Phu L, Forrest WF, Stawiski E, Schmidt S, Endres N, Guan J, Wallin JJ, Cheong J, Plise EG, Lewis Phillips GD, Salphati L, Heffron TP, Olivero AG, Malek S, Staben ST, Kirkpatrick DS, Dey A, Friedman LS. Song KW, et al. Cancer Discov. 2022 Jan;12(1):204-219. doi: 10.1158/2159-8290.CD-21-0072. Epub 2021 Sep 20. Cancer Discov. 2022. PMID: 34544753 Free PMC article.
A novel S-enantioselective amidase acting on 3,3,3-trifluoro-2-hydroxy-2-methylpropanamide from Arthrobacter sp. S-2.
Fuhshuku K, Watanabe S, Nishii T, Ishii A, Asano Y. Fuhshuku K, et al. Biosci Biotechnol Biochem. 2015;79(10):1587-96. doi: 10.1080/09168451.2015.1038216. Epub 2015 May 26. Biosci Biotechnol Biochem. 2015. PMID: 26011254
A novel S-enantioselective amidase acting on 3,3,3-trifluoro-2-hydroxy-2-methylpropanamide was purified from Arthrobacter sp. S-2. The enzyme acted S-enantioselectively on 3,3,3-trifluoro-2-hydroxy-2-methylpropanamide to yield (S)-3,3,3-trifluoro-2-hyd …
A novel S-enantioselective amidase acting on 3,3,3-trifluoro-2-hydroxy-2-methylpropanamide was purified from Arthrobacter sp. …
The complex balance of PI3K inhibition.
Vanacker H, Cassier PA, Bachelot T. Vanacker H, et al. Ann Oncol. 2021 Feb;32(2):127-128. doi: 10.1016/j.annonc.2020.10.597. Epub 2020 Nov 30. Ann Oncol. 2021. PMID: 33272746 Free article. No abstract available.
Discovery of (2S)-N-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment.
Zhang W, Zhao S, Luo Y, Zhang Y, Feng Y, Tang F, Zhou X, Peng S, Fan Y, Xie S, Li H, Lai Q, Fu L, Luo Y, Pei S, Chen Z, Lu T, Tang R, Chen Y, Jiao Y. Zhang W, et al. J Med Chem. 2024 Jan 11;67(1):322-348. doi: 10.1021/acs.jmedchem.3c01417. Epub 2023 Dec 21. J Med Chem. 2024. PMID: 38128906
Outstanding Issues with Umbrella and Basket Studies.
Parikh K, Adjei AA. Parikh K, et al. J Thorac Oncol. 2019 Oct;14(10):1685-1688. doi: 10.1016/j.jtho.2019.08.011. J Thorac Oncol. 2019. PMID: 31558226 Free article. No abstract available.
SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]-4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin 1 receptor: II. Neurochemical and behavioral characterization.
Steinberg R, Alonso R, Rouquier L, Desvignes C, Michaud JC, Cudennec A, Jung M, Simiand J, Griebel G, Emonds-Alt X, Le Fur G, Soubrié P. Steinberg R, et al. J Pharmacol Exp Ther. 2002 Dec;303(3):1180-8. doi: 10.1124/jpet.102.040279. J Pharmacol Exp Ther. 2002. PMID: 12438542
SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]-4-piperidinyl)-2-methylpropanamide], a new nonpeptide tachykinin neurokinin 1 (NK1) receptor antagonist, was evaluated against the neurochemical, electro …
SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]-4-piperidinyl)-2- …
Butyrate trials.
Cappellini MD, Graziadei G, Ciceri L, Comino A, Bianchi P, Pomati M, Fiorelli G. Cappellini MD, et al. Ann N Y Acad Sci. 1998 Jun 30;850:110-9. doi: 10.1111/j.1749-6632.1998.tb10468.x. Ann N Y Acad Sci. 1998. PMID: 9668533 Clinical Trial.
The aims of this study were to ascertain tolerability, safety and efficacy of oral isobutyramide (150 mg/kg bw/day) in stimulating fetal hemoglobin production in twelve thalassemia intermedia patients. ...
The aims of this study were to ascertain tolerability, safety and efficacy of oral isobutyramide (150 mg/kg bw/day) in stimulating fe …
SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization.
Emonds-Alt X, Proietto V, Steinberg R, Oury-Donat F, Vigé X, Vilain P, Naline E, Daoui S, Advenier C, Le Fur G, Maffrand JP, Soubrié P, Pascal M. Emonds-Alt X, et al. J Pharmacol Exp Ther. 2002 Dec;303(3):1171-9. doi: 10.1124/jpet.102.040162. J Pharmacol Exp Ther. 2002. PMID: 12438541
The biochemical and pharmacological properties of a novel antagonist of the tachykinin neurokinin 1 (NK1) receptor, SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]-4-piperidinyl)-2-methylpropanamide], …
The biochemical and pharmacological properties of a novel antagonist of the tachykinin neurokinin 1 (NK1) receptor, SSR240600 [(R)-2-(1-[2-[ …
227 results